Home
Castle Biosciences CSTL paid McDermott+ $40K for lobbying in Q2 2026 · Medicare
Trade details
- Type
- Lobbying report
- Amount
- $40,000
- Quarter
- Q2 2026
- Client
- Castle Biosciences
- Reported
- 26/07/06
Up 0.0% from last quarter
What else happened in Castle Biosciences around then
Filed or reported within 30 days of the trade day · 05/31~07/30Castle Biosciences's other lobbying reports
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 04/02
for Q1
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 01/05
for Q4 2025
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 25/10/03
for Q3 2025
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 25/06/30
for Q2 2025
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 25/04/08
for Q1 2025